Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.05B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$404M |
| 3 |
AstraZeneca
AZN
|
+$342M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$288M |
| 5 |
Willis Towers Watson
WTW
|
+$227M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Icahn Enterprises
IEP
|
+$641M |
| 2 |
Microsoft
MSFT
|
+$549M |
| 3 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$538M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$294M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.22% |
| 2 | Financials | 7.52% |
| 3 | Healthcare | 6.46% |
| 4 | Consumer Discretionary | 6.41% |
| 5 | Communication Services | 4.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Ralph Lauren
RL
$22.4B
| $4.94M | ﹤0.01% |
41,948
+4,147
| +11% | +$519K |
|
1877
C3.ai
AI
$1.38B
| $4.94M | ﹤0.01% |
78,976
+24,872
| +46% | +$1.55M |
|
1878
CALL
Duke Energy
DUK
$101B
| $4.94M | ﹤0.01% |
50,000
-36,000
| -42% | -$3.62M |
|
1879
CALL
Linde
LIN
$236B
| $4.92M | ﹤0.01% |
17,000
-40,000
| -70% | -$11.7M |
|
1880
CALL
APA Corp
APA
$13B
| $4.91M | ﹤0.01% |
227,000
| – | – |
|
1881
Energizer
ENR
$1.47B
| $4.9M | ﹤0.01% |
113,989
-71,053
| -38% | -$3.33M |
|
1882
Vir Biotechnology
VIR
$1.46B
| $4.89M | ﹤0.01% |
103,489
+8,298
| +9% | +$377K |
|
1883
National Beverage
FIZZ
$3.06B
| $4.89M | ﹤0.01% |
103,509
+52,038
| +101% | +$2.52M |
|
1884
iShares Russell Mid-Cap Value ETF
IWS
$15.7B
| $4.88M | ﹤0.01% |
42,445
+1,411
| +3% | +$162K |
|
|
FOLD
1885
DELISTED
Amicus Therapeutics
FOLD
| $4.88M | ﹤0.01% |
505,805
+73,010
| +17% | +$713K |
|
1886
NeoGenomics
NEO
$1.99B
| $4.87M | ﹤0.01% |
107,775
+75,140
| +230% | +$3.33M |
|
1887
Mitek Systems
MITK
$756M
| $4.87M | ﹤0.01% |
252,674
+45,724
| +22% | +$769K |
|
1888
PUT
American Tower
AMT
$83.5B
| $4.86M | ﹤0.01% |
+18,000
| New | +$4.59M |
|
1889
Insmed
INSM
$22.4B
| $4.86M | ﹤0.01% |
170,829
+45,436
| +36% | +$1.35M |
|
|
MIME
1890
DELISTED
Mimecast Limited
MIME
| $4.86M | ﹤0.01% |
91,641
-2,920
| -3% | -$137K |
|
1891
Polaris
PII
$3.83B
| $4.86M | ﹤0.01% |
35,485
-6,325
| -15% | -$857K |
|
1892
PUT
Marathon Petroleum
MPC
$90.1B
| $4.86M | ﹤0.01% |
80,400
-631,000
| -89% | -$37M |
|
1893
Arcturus Therapeutics
ARCT
$165M
| $4.86M | ﹤0.01% |
143,507
+59,686
| +71% | +$2.02M |
|
1894
PUT
Logitech
LOGI
$14.8B
| $4.85M | ﹤0.01% |
40,000
-185,000
| -82% | -$21.6M |
|
|
SC
1895
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $4.85M | ﹤0.01% |
133,412
+18,161
| +16% | +$631K |
|
1896
Seres Therapeutics
MCRB
$45M
| $4.84M | ﹤0.01% |
10,143
+119
| +1% | +$50.2K |
|
1897
Williams-Sonoma
WSM
$27.5B
| $4.83M | ﹤0.01% |
60,546
+1,132
| +2% | +$96.3K |
|
1898
ManpowerGroup
MAN
$2.6B
| $4.83M | ﹤0.01% |
40,641
+5,690
| +16% | +$672K |
|
1899
First Trust Municipal High Income ETF
FMHI
$991M
| $4.83M | ﹤0.01% |
+85,817
| New | +$4.77M |
|
1900
Royalty Pharma
RPRX
$26.2B
| $4.82M | ﹤0.01% |
117,645
-47,690
| -29% | -$2.03M |
|
Similar funds
Citigroup's Q2 2021 Portfolio in Review
As of Q2 2021, Citigroup held 6,654 positions worth $166B, up 7.5% from $155B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup's Q2 2021 filing shows 397 new, 2,681 increased, 2,205 reduced and 444 closed positions. Its largest new stake was Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant: 7,128,000 shares worth $71.4M. The largest sale was Icahn Enterprises, an estimated $641M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
- Citigroup's largest Q2 2021 buy was Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant: 7,128,000 shares worth $71.4M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $2.05B increase.
- Citigroup's biggest Q2 2021 reduction was Icahn Enterprises, cutting an estimated $641M.
- Citigroup fully exited RealPage, Inc. in Q2 2021, selling an estimated $226M.
- Citigroup's ten largest holdings make up 20% of its $166B portfolio in Q2 2021.
- Citigroup opened 397 new positions and closed 444 in Q2 2021.
- Citigroup's portfolio value rose 7.5% quarter-over-quarter to $166B.
Based on Citigroup's 13F filing for Q2 2021, filed 10 Aug 2021.